MDLN Stock Risk & Deep Value Analysis
Medline Inc
Healthcare • Medical Instruments & Supplies
DVR Score
out of 10
What You Need to Know About MDLN Stock
We analyzed Medline Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran MDLN through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: N/A - Risk assessment for a hypothetical public listing. As a private company, the risks are primarily operational and strategic, not investment-specific for public shareholders.. Here's what we found.
MDLN Risk Analysis & Red Flags
What Could Go Wrong
As a private entity, Medline's primary risks involve operational inefficiencies, supply chain disruptions, intense competition in the healthcare distribution market, and potential shifts in healthcare policy affecting demand and pricing. Any significant misstep in these areas could impact its valuation if it were to ever consider a public offering.
Risk Matrix
Overall
N/A - Risk assessment for a hypothetical public listing. As a private company, the risks are primarily operational and strategic, not investment-specific for public shareholders.
Financial
Medium
Market
Medium
Competitive
Medium
Execution
Medium
Regulatory
Medium
Red Flags
- ⚠
Private company status means no public financial disclosures for investor analysis.
- ⚠
Lack of liquidity and public market access.
- ⚠
Mature industry with strong incumbents limits potential for exponential growth typically required for a 10x return.
Upcoming Risk Events
- 📅
N/A - Company is privately held. No public market risk events for the stock.
When to Reconsider
- 🚪
N/A - Company is privately held; no sell signals for a public stock.
- 🚪
N/A - Company is privately held; no sell signals for a public stock.
Unlock MDLN Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Medline Inc (MDLN) Do?
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
43,000
Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services such as, consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. Medline Inc. was founded in 1966 and is based in Northfield, Illinois.
Visit Medline Inc WebsiteInvestment Thesis
N/A - As Medline Inc. is a privately held company, there is no public investment thesis for its stock. The company itself is a robust, essential player in the healthcare supply chain, but it is not available for public equity investment.
Is MDLN Stock Undervalued?
Unlock the full AI analysis for MDLN
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
MDLN Price Targets & Strategy
Valuation Basis
N/A - Medline Inc. is a privately held company; therefore, traditional public market price targets and valuation metrics are not applicable.
Entry Strategy
N/A - Medline Inc. is a privately held company; its shares are not publicly traded.
Exit Strategy
N/A - Medline Inc. is a privately held company; its shares are not publicly traded.
Portfolio Allocation
N/A - Medline Inc. is a privately held company; its shares are not publicly traded.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Does MDLN Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Stable
Moat Sources
3 Identified
Medline's moat stems from its enormous scale in purchasing and distribution, which allows for significant cost advantages over smaller competitors. The integrated nature of its services (supply chain, product manufacturing, clinical solutions) creates switching costs for customers, as migrating to a new provider is disruptive and costly. This moat is durable but operates in a highly competitive and regulated industry.
Moat Erosion Risks
- •Intensifying competition from other large distributors like Cardinal Health, McKesson, and Owens & Minor.
- •Healthcare cost containment pressures from insurers and government could squeeze margins.
- •Supply chain disruptions or significant changes in regulatory landscape.
MDLN Competitive Moat Analysis
Sign up to see competitive advantages
MDLN Market Intelligence
Sentiment & Insider Activity
Social Sentiment
N/A - No public stock, thus no direct retail investor sentiment.
Institutional Sentiment
N/A - No public stock, thus no analyst ratings or institutional sentiment.
Insider Activity (Form 4)
N/A - No public stock, therefore no insider trading filings (Form 4).
Options Flow
N/A - No public stock, therefore no options trading data. Normal options activity for non-existent stock.
Earnings Intelligence
Next Earnings
N/A - Company is privately held; does not report public earnings.
Surprise Probability
N/A - Company is privately held.
Historical Earnings Pattern
N/A - Company is privately held.
Key Metrics to Watch
Competitive Position
Top Competitor
Cardinal Health (CAH)
Market Share Trend
Stable
Valuation vs Peers
N/A - As a private entity, direct public market valuation comparison is not applicable. However, public peers like CAH and OMI typically trade at modest multiples reflecting the mature, low-margin nature of the healthcare distribution industry.
Competitive Advantages
- •Vast, efficient distribution network for medical supplies.
- •Strong relationships with healthcare providers (hospitals, labs, etc.).
- •Large product portfolio including both manufactured and distributed goods.
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive MDLN Stock Higher?
Near-Term (0-6 months)
- •N/A - Company is privately held. No public market catalysts.
Medium-Term (6-18 months)
- •N/A - Company is privately held. No public market catalysts.
Long-Term (18+ months)
- •N/A - Company is privately held. No public market catalysts.
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for MDLN?
- ✓
N/A - Not applicable for a private company.
- ✓
N/A - Not applicable for a private company.
Bull Case Analysis
See what could go right with Premium
Competing with MDLN
See how Medline Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Medline Inc MDLN | — | 0.1 | — | — | — | — | |
AbbVie Inc ABBV | $403.8B | 0.1 | 171.8 | — | — | — | Compare → |
Johnson & Johnson JNJ | — | 1.0 | — | — | — | — | Compare → |
Eli Lilly and Co LLY | $965.0B | 0.5 | 52.6 | — | — | — | Compare → |
Pfizer Inc PFE | $150.6B | 0.2 | 19.4 | $62.6B | 12.4% | -1.6% | Compare → |
UnitedHealth Group Inc UNH | $276.2B | 0.3 | 22.9 | $113.7B | 2.7% | 1181.0% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
FAQ
What is the DVR Score for Medline Inc (MDLN)?
As of March 29, 2026, Medline Inc has a DVR Score of 0.1 out of 10, placing it in the "Distressed" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What ticker symbol does Medline Inc use?
MDLN is the ticker symbol for Medline Inc. The company trades on the NGM.
What is the risk level for MDLN stock?
Our analysis rates Medline Inc's overall risk as N/A - Risk assessment for a hypothetical public listing. As a private company, the risks are primarily operational and strategic, not investment-specific for public shareholders.. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
How often is the MDLN DVR analysis updated?
Our AI-powered analysis of Medline Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 29, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for MDLN (Medline Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.